MELTZER LESLIE (Chief Research and Development) received a stock award from APELLIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
Common Stock
Shares
−107.02K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+22.61K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−22.61K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+45.22K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−45.22K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−61.80K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−45.22K
Price / share
—
Trade value
—
% of position
Net shares
−214.05K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2026 | U · U | −107.02K | — | — | New position | 107.02K | 0.00 |
| Common Stock Direct | 5/14/2026 | A · Award | +22.61K | — | — | New position | 0.00 | 22.61K |
| Common Stock Direct | 5/14/2026 | D · Disposition | −22.61K | — | — | New position | 22.61K | 0.00 |
| Common Stock Direct | 5/14/2026 | A · Award | +45.22K | — | — | New position | 0.00 | 45.22K |
| Common Stock Direct | 5/14/2026 | D · Disposition | −45.22K | — | — | New position | 45.22K | 0.00 |
| Common Stock Direct | 5/14/2026 | D · Disposition | −61.80K | — | — | New position | 61.80K | 0.00 |
| Common Stock Direct | 5/14/2026 | D · Disposition | −45.22K | — | — | New position | 45.22K | 0.00 |
| Total | −214.05K | $0.00 | ||||||
Stock Option (right to buy)
Common Stock
92.59K shares
Shares
−92.59K
Strike price
27.93
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock92.59K shares | 5/14/2026 | D · Disposition | −92.59K | 27.93 | — | 0.00 |